CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,169,511 | +6.6% | 239,725 | +26.8% | 0.00% | 0.0% |
| Q2 2023 | $2,034,425 | +81212.0% | 189,073 | -22.7% | 0.00% | 0.0% |
| Q1 2023 | $2,502 | +10.7% | 244,553 | +14.1% | 0.00% | 0.0% |
| Q4 2022 | $2,261 | -99.9% | 214,269 | +43.4% | 0.00% | 0.0% |
| Q3 2022 | $1,915,000 | -53.6% | 149,407 | -53.6% | 0.00% | -66.7% |
| Q2 2022 | $4,124,000 | +3649.1% | 321,684 | +2959.3% | 0.00% | – |
| Q1 2022 | $110,000 | -97.6% | 10,515 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $4,673,000 | -22.3% | 207,030 | -11.4% | 0.00% | -25.0% |
| Q2 2021 | $6,017,000 | -64.2% | 233,661 | -42.1% | 0.00% | -66.7% |
| Q1 2021 | $16,828,000 | – | 403,836 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |